EDGAR Filing Documents for 0001193125-21-101240

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-21-101240

Filing Date

2021-03-31

Accepted

2021-03-31 06:38:20

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d165576ds3.htm	S-3	317299
2	EX-4.2	d165576dex42.htm	EX-4.2	301135
3	EX-4.3	d165576dex43.htm	EX-4.3	325972
4	EX-4.4	d165576dex44.htm	EX-4.4	47036
5	EX-4.5	d165576dex45.htm	EX-4.5	45356
6	EX-5.1	d165576dex51.htm	EX-5.1	39857
7	EX-5.2	d165576dex52.htm	EX-5.2	6556
8	EX-23.1	d165576dex231.htm	EX-23.1	1736
9	GRAPHIC	g165576g03m99.jpg	GRAPHIC	38816
10	GRAPHIC	g165576g29v48.jpg	GRAPHIC	36381
11	GRAPHIC	g165576g30u88.jpg	GRAPHIC	36463
12	GRAPHIC	g165576g40p24.jpg	GRAPHIC	42281
13	GRAPHIC	g165576g47c54.jpg	GRAPHIC	20177
14	GRAPHIC	g165576g53z97.jpg	GRAPHIC	25861
	Complete submission text file	0001193125-21-101240.txt		1344941

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612

Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090

Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)